succimer has been researched along with Schistosomiasis* in 29 studies
29 other study(ies) available for succimer and Schistosomiasis
Article | Year |
---|---|
Microencapsulation of astiban acid for the treatment of Schistosomiasis mansoni.
Schistosomiasis is among the top five diseases in the world in terms of morbidity, affecting perhaps 200 million people in tropical and subtropical countries. Antischistosomal drugs are toxic and rapidly metabolized. Hence, they must be given in a number of spaced doses. In spite of this there are severe side effects leading to poor patient compliance. This is an ideal situation for the application of sustained drug release to avoid the toxic peak concentration of drug. This study was carried out using Astiban acid, an antimonial drug that is effective against S. mansoni. Unfortunately, the drug is sufficiently soluble that 50 mg will dissolve in 100 mL water in less than a minute. To permit sustained release of intramuscularly injected drug, microcapsules of astiban acid in poly(d,l-lactic acid) were formed by coacervation. Release studies show that an appreciable fraction of the drug is available at the surface for rapid solution. After this surface drug dissolves, the remaining drug is released slowly with half-times of many hours. After the initial burst, the release of drug follows Higuchi's equation up to approximately 80% release, with exponentially decreasing release rates thereafter. Topics: Antimony; Capsules; Humans; Lactates; Lactic Acid; Organometallic Compounds; Polyesters; Polymers; Schistosoma mansoni; Schistosomiasis; Schistosomicides; Succimer; Sulfhydryl Compounds | 1984 |
Schistosoma mansoni: an in vivo study of drug-induced autophagy in the gastrodermis.
The effects of Astiban, Lucanthone, Hycanthone and Niridazole on autophagic activities in the gastrodermis of Schistosoma mansoni were determined in vivo, using different dosage levels and dosage times. With Astiban, high levels of autophagy were observed in the gastrodermis 2 hours after an injection of the drug into the mouse, and this response had declined by 20 hours, marking a recovery by the parasite from the drug. Hycanthone and Lucanthone produced an autophagic response several days after the onset of treatment, and no recovery was observed in the morphology of the gastrodermis after the drug was discontinued. The effects of Niridazole on the gastrodermis were to produce the most dramatic ultrastructural changes after high doses and over several days of treatment. With all the drugs examined, gastrodermal autophagy was characterized by the formation of vacuoles containing cell components, lipid droplets and sometimes hydrolytic enzyme reaction product. The autophagic vacuoles appeared to be formed by the sequestration of cytoplasmic material by the basal membrane infoldings, and the transfer of enzymes into the vacuole from within the limiting membrane. The residues from intracellular digestion appeared to be emptied into the caecal lumen. Topics: Animals; Antimony; Hycanthone; Lucanthone; Mice; Niridazole; Organometallic Compounds; Schistosoma mansoni; Schistosomiasis; Schistosomicides; Succimer | 1984 |
[Schistosomiasis clinically active for 25 years].
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Succimer; Sulfhydryl Compounds; Time Factors | 1980 |
Fatal stibocaptate toxicity.
Topics: Aged; Antimony; Child, Preschool; Female; Humans; Organometallic Compounds; Schistosomiasis; Succimer; Sulfhydryl Compounds | 1980 |
Influence of astiban on liver, spleen kidney and bladdet beta.glucuronidase of normal and Schistosoma mansoni infected mice.
Topics: Animals; Antimony; Glucuronidase; Kidney; Liver; Mice; Organometallic Compounds; Schistosoma mansoni; Schistosomiasis; Spleen; Succimer; Sulfhydryl Compounds; Time Factors; Urinary Bladder | 1979 |
THERAPEUTIC RESULTS OBTAINED WITH INTRAMUSCULAR ASTIBAN IN URINARY SCHISTOSOMIASIS.
Topics: Africa; Africa, Western; Antimony; Child; Drug Therapy; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1965 |
[TREATMENT OF MANSON'S SCHISTOSOMIASIS WITH DIMERCAPTO-SUCCINATE OF ANTIMONY AND SODIUM (ASTIBAN)].
Topics: Antimony; Humans; Ions; Organometallic Compounds; Schistosomiasis; Sodium; Sodium, Dietary; Succimer; Succinates; Succinic Acid | 1964 |
"ASTIBAN" THERAPY IN BILHARZIASIS; ITS URINARY EXCRETION ESTIMATED BY A NEW POLAROGRAPHIC TECHNIQUE.
Topics: Antimony; Body Fluids; Organometallic Compounds; Polarography; Schistosomiasis; Succimer; Toxicology; Urine | 1964 |
CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: PROPHYLACTIC, PROTECTIVE AND THERAPEUTIC ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID IN MICE AND HAMSTERS.
Topics: Animals; Antimony; Cricetinae; Dosage Forms; Mice; Organometallic Compounds; Pharmacology; Research; Schistosomiasis; Schistosomiasis mansoni; Sodium; Succimer; Succinates | 1964 |
ASTIBAN IN SCHISTOSOMIASIS MANSONI: A CONTROLLED THERAPEUTIC TRIAL IN A NONENDEMIC AREA.
Topics: Adolescent; Antimony; Biomedical Research; Drug Therapy; Organometallic Compounds; Schistosomiasis; Schistosomiasis mansoni; Succimer; Toxicology | 1964 |
TREATMENT OF URINARY SCHISTOSOMIASIS IN GHANAIANS WITH TWSB (ASTIBAN).
Topics: Adolescent; Africa; Africa, Western; Antimony; Child; Drug Therapy; Ghana; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Toxicology | 1964 |
CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: INFLUENCE OF DIMERCAPTOSUCCINIC ACID ON THE TOXICITY AND ANTISCHISTOSOMAL ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND OTHER ANTIMONY COMPOUNDS IN MICE.
Topics: Antimony; Antiprotozoal Agents; Emetine; Mice; Organometallic Compounds; Pharmacology; Research; Schistosomiasis; Schistosomiasis mansoni; Sodium; Succimer; Succinates | 1964 |
CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: DISTRIBUTION OF ANTIMONY-124 IN MICE AND HAMSTERS AFTER A SINGLE DOSE OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID.
Topics: Animals; Antimony; Blood; Chemical Phenomena; Chemistry; Cricetinae; Intestines; Kidney; Liver; Mice; Organometallic Compounds; Pharmacology; Radioisotopes; Research; Schistosomiasis; Schistosomiasis mansoni; Sodium; Succimer; Succinates | 1964 |
Observations on the treatment of schistosomiasis mansoni with antimony dimercaptosuccinate (TWSb).
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis mansoni; Succimer | 1963 |
The suppressive activity of sodium antimony dimercaptosuccinate (TWSB) in experimental infections with Schistosoma mansoni.
Topics: Animals; Antimony; Antiparasitic Agents; Humans; Organometallic Compounds; Schistosoma mansoni; Schistosomiasis; Sodium; Succimer | 1963 |
ON THE SHORT-TERM ANTIBILHARZIAL THERAPY WITH SODIUM ANTIMONY DIMERCAPTOSUCCINATE.
Topics: Acids, Noncarboxylic; Antimony; Humans; Organometallic Compounds; Schistosomiasis; Sodium; Sodium, Dietary; Succimer; Succinates; Toxicology | 1963 |
Ambulant treatment of urinary schistosomiasis with Astiban (TWSb/6).
Topics: Antimony; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1962 |
Electrocardiographic effects of antimony dimercapto-succinate ('astiban').
Topics: Antimony; Electrocardiography; Organometallic Compounds; Schistosomiasis; Succimer; Succinates; Succinic Acid | 1962 |
Astiban in treatment of urinary bilharziasis in Iraq.
Topics: Antimony; Humans; Iraq; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1962 |
Fatality after antimony dimercapto-succinate ("Astiban").
Topics: Antimony; Hepatitis; Hepatitis A; Organometallic Compounds; Schistosomiasis; Shock, Septic; Succimer; Succinates; Succinic Acid | 1962 |
A comparison of Astiban (Twsb) and Miracil D in the therapy of school children suffering from urinary bilharziasis in Iraq.
Topics: Antimony; Iraq; Lucanthone; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1962 |
Cardiotoxic effects of antimony dimercaptosuccinate in schistosomiasis with special reference to coexistent hepatic dysfunction.
Topics: Antimony; Heart; Humans; Liver Diseases; Organometallic Compounds; Schistosomiasis; Succimer; Succinates; Sulfhydryl Compounds | 1962 |
Treatment of Schistosoma haematobium infection with sodium antimony dimercaptosuccinate (TWSb).
Topics: Animals; Antimony; Humans; Organometallic Compounds; Schistosoma haematobium; Schistosomiasis; Schistosomiasis haematobia; Sodium; Sodium, Dietary; Succimer | 1962 |
Suppressive management of schistosomiasis with antimony dimercaptosuccinate.
Topics: Antimony; Organometallic Compounds; Schistosomiasis; Succimer | 1961 |
[Treatment of schistosomiasis mansoni by antimony dimercaptosuccinate (TWSb). Comparison with tartar emetic].
Topics: Antimony; Antimony Potassium Tartrate; Organometallic Compounds; Schistosomiasis; Schistosomiasis mansoni; Succimer | 1961 |
Antimony dimercaptosuccinate (TWSb) in the treatment of urinary bilharziasis in Somalia.
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Somalia; Succimer; Urinary Tract Infections | 1960 |
Sodium antimony dimercaptosuccinate (Sb-58) in treatment of schistosomiasis japonica.
Topics: Acids, Noncarboxylic; Antimony; Organometallic Compounds; Schistosomiasis; Schistosomiasis japonica; Sodium; Sodium, Dietary; Succimer; Succinates | 1960 |
Treatment of urinary bilharziasis with antimony dimercaptosuccinate (TWSb).
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Succinates; Urologic Diseases | 1958 |
Treatment of bilharziasis with antimony dimercaptosuccinate.
Topics: Antimony; Organometallic Compounds; Schistosomiasis; Succimer | 1958 |